In addition, TNK2 could stimulate PDGFR-β activity and AKT activation to promote tumor cell cycle progression, proliferation, and tumorigenesis and played a pivotal role in PDGFR-induced AKT signaling in glioma tumorigenesis [34]. The gene discussed is TNK2; the disease is neoplasm.